ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,521, issued on May 6, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).
"Methods and materials for identifying and treating BET inhibitor-resistant cancers" was invented by Haojie Huang (Rochester, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and materials involved in identifying and treating mammals having a cancer resistant to BET inhibitors are provided. For example, methods and materials for administering (a) one or more AKT inhibitors and/or one or more CDK inhibitors and/or one or more CBP/p300 inhibitors in combination with (b) one or more BET inhibitors to mammals identified as having a ca...